Why is Scotts Miracle-Gro stock climbing today?
Scotts Miracle-Gro (SMG) shares rose 1.8% pre-open after the company held Investor Day 2026 and set mid-range targets for FY2027-2029, including 2% to 4% average annual net sales growth, adjusted EPS growth of 5% to 8%, and free cash flow above $275 million. Stifel raised its FY2026 EPS estimate to $4.44 and lifted its price target to $76.
How this was made
The 30-second read
Why it matters
The combination of concrete multi-year targets, management confidence in the SMG 2.0 strategy, and a same-day Stifel price-target increase provides a clear valuation narrative for traders to reassess expectations.
Market read
Traders get a fresh multi-year guidance framework plus an analyst PT update, which can drive positioning into the open.
What to watch
The article does not detail assumptions behind the 2% to 4% sales growth or the drivers of the 50 to 100 bps gross margin improvement, which could be where skepticism emerges.
Background
The piece attributes SMG’s move to an Investor Day 2026 with mid-range financial targets for FY2027-2029 and notes analyst follow-through after a prior quarterly earnings beat.
Ticker impact
Scotts Miracle-Gro held Investor Day 2026 and issued FY2027-2029 targets, including net sales growth 2% to 4% and adjusted EPS growth 5% to 8%.
Near-term upside bias as traders price in the 2027-2029 profitability and free-cash-flow targets, with follow-through risk if the market focuses on execution rather than guidance.
The article cites specific multi-year financial targets and a same-day analyst PT increase, which are actionable inputs for valuation and positioning, but it does not provide new quarter results or incremental surprises beyond the Investor Day framework.
Market effects
Supports the consumer discretionary and lawn-and-garden retail/inputs complex by signaling improved profitability expectations and cash generation.
Primarily US-focused, with the NYSE Investor Day venue and US index strength providing a tailwind.
Limited direct global spillover; the catalyst is company-specific and tied to US consumer demand and capital allocation.
Counterpoint
Multi-year targets can be less informative than near-term execution; the stock may fade if investors demand evidence of accelerating demand or margin durability.
Key entities
- companyScotts Miracle-Gro
Investor Day 2026 disclosed FY2027-2029 net sales, margin, EPS, and free-cash-flow targets.
- analyst_firmStifel
Raised its SMG price target to $76 from $75 and maintained a Buy rating.
- executiveNate Baxter
CEO who stated the company is on a clear path to meet or exceed FY2026 commitments.